Related Experiment Video
Updated: Jan 13, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
An interpretable multimodal deep learning framework for Alzheimer's disease diagnosis
1Department of Computer Engineering, College of Computer and Information Sciences, Majmaah University, Majmaah, Saudi Arabia.
Digital Health
|October 28, 2025
Summary
This study introduces NeuroFusion-ADNet, an AI model that combines MRI and PET scans for accurate Alzheimer's disease diagnosis. The explainable AI approach enhances early detection and clinical interpretability.
Area of Science:
- Artificial Intelligence in Medical Imaging
- Neuroscience and Neuroimaging
- Biomedical Data Science
Background:
- Alzheimer's disease (AD) poses a growing public health challenge, with early neurodegeneration often missed by current diagnostics.
- Medical imaging, including MRI and PET, offers insights into AD-related brain changes but integration into AI frameworks is limited.
- Developing explainable AI for multimodal imaging is crucial for advancing AD diagnosis.
Purpose of the Study:
- To develop and evaluate NeuroFusion-ADNet, a novel AI model for improved Alzheimer's disease diagnosis.
- To enhance diagnostic accuracy and clinical interpretability by combining structural MRI and functional PET data.
- To create a transparent and explainable AI framework for early AD detection.
Main Methods:
- A dual-path deep learning model, NeuroFusion-ADNet, was designed to jointly process MRI and PET data.
- The model incorporates modality-specific encoders, a cross-attention fusion layer, and a segmentation-informed classification module.
- Explainability features, including attention heatmaps and Local Interpretable Model-Agnostic Explanations, were integrated.
Main Results:
- NeuroFusion-ADNet achieved 99.48% classification accuracy and a 0.985 Dice coefficient, outperforming baseline models.
- Attention visualizations highlighted the model's focus on clinically relevant brain regions like the hippocampus and entorhinal cortex.
- Ablation studies confirmed the significance of individual architectural components.
Conclusions:
- This study presents a clinically promising, multimodal AI framework for Alzheimer's disease diagnosis.
- NeuroFusion-ADNet enhances diagnostic accuracy and transparency through explainable AI techniques.
- The developed framework provides a foundation for efficient, interpretable, and deployable tools for early AD detection.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806

